Site rotation between injections helps prevent localized reactions and ensures consistent absorption
However, uptake transporter assays indicated that ATSP-7041 acts as both a substrate for OATPs and a potent inhibitor of OATP1B1 (IC 50 : 0.81 M), suggesting the potential for clinically relevant DDIs
Side effects are one contributing factor with respect to discontinuation
Research applications Documented research applications for Retatrutide span several preclinical domains
Researchers continue monitoring gastrointestinal symptoms, hydration, appetite, fatigue, and participant tolerance after additional dose adjustments
Individuals with certain chronic diseases, pregnant or breastfeeding women, and those allergic to specific peptides should consult their primary care physician before starting their treatment